Shire Stock Rising on Takeover Talks
Shire is a biotech company that is focused on serving people with rare diseases and other specialized conditions.

Shares of Shire PLC (SHPG) were gaining by more than 3% to $168.97 on Wednesday, following talk of a takeover of the specialty drug maker.

Some of the largest drug firms in the U.S. and across Europe are said to have hired advisers regarding a move at the Dublin-based company, the Evening Standard reports. Shire is also said to have hired its own defense advisers to ward off low bids.

Shire is a biotech company that is focused on serving people with rare diseases and other specialized conditions.

More of What's Trending on TheStreet:

More from Stocks

Nucor Shares Retreat Despite Nearly Doubling Q2 Earnings

Nucor Shares Retreat Despite Nearly Doubling Q2 Earnings

Microsoft Climbs After-Hours on Earnings Beat; Guidance to Be Announced on Call

Microsoft Climbs After-Hours on Earnings Beat; Guidance to Be Announced on Call

Dow Falls, Breaking 5-Day Winning Streak on Beige Book Trade-War Worries

Dow Falls, Breaking 5-Day Winning Streak on Beige Book Trade-War Worries

3 Must Reads on the Market From TheStreet's Top Columnists

3 Must Reads on the Market From TheStreet's Top Columnists

Nucor Retains Buy Recommendation From TheStreet Ratings

Nucor Retains Buy Recommendation From TheStreet Ratings